Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACAD |
---|---|---|
09:32 ET | 10971 | 15.74 |
09:34 ET | 1749 | 15.73 |
09:36 ET | 2433 | 15.8 |
09:38 ET | 7024 | 15.63 |
09:39 ET | 4135 | 15.61 |
09:41 ET | 500 | 15.59 |
09:43 ET | 1400 | 15.65 |
09:45 ET | 550 | 15.645 |
09:48 ET | 5886 | 15.55 |
09:50 ET | 3960 | 15.57 |
09:52 ET | 14829 | 15.58 |
09:54 ET | 14641 | 15.58 |
09:56 ET | 7392 | 15.5694 |
09:57 ET | 2800 | 15.57 |
09:59 ET | 200 | 15.61 |
10:01 ET | 9591 | 15.605 |
10:03 ET | 600 | 15.58 |
10:06 ET | 4132 | 15.53 |
10:08 ET | 7225 | 15.49 |
10:10 ET | 4081 | 15.52 |
10:12 ET | 2957 | 15.52 |
10:14 ET | 1608 | 15.49 |
10:15 ET | 2516 | 15.48 |
10:17 ET | 25179 | 15.4999 |
10:19 ET | 8123 | 15.52 |
10:21 ET | 13304 | 15.515 |
10:24 ET | 7294 | 15.49 |
10:26 ET | 409 | 15.49 |
10:28 ET | 9562 | 15.45 |
10:30 ET | 11011 | 15.495 |
10:32 ET | 3284 | 15.49 |
10:33 ET | 6488 | 15.49 |
10:35 ET | 2376 | 15.47 |
10:37 ET | 1200 | 15.46 |
10:39 ET | 2800 | 15.49 |
10:42 ET | 1418 | 15.45 |
10:44 ET | 900 | 15.455 |
10:46 ET | 3929 | 15.44 |
10:48 ET | 6178 | 15.458 |
10:50 ET | 7989 | 15.5 |
10:51 ET | 1161 | 15.49 |
10:53 ET | 1215 | 15.49 |
10:55 ET | 2380 | 15.47 |
10:57 ET | 2849 | 15.44 |
11:00 ET | 634 | 15.43 |
11:02 ET | 3591 | 15.41 |
11:04 ET | 6904 | 15.42 |
11:06 ET | 1237 | 15.42 |
11:08 ET | 1419 | 15.42 |
11:09 ET | 767 | 15.4 |
11:11 ET | 650 | 15.4 |
11:13 ET | 5401 | 15.405 |
11:15 ET | 1050 | 15.39 |
11:18 ET | 200 | 15.37 |
11:20 ET | 9175 | 15.38 |
11:22 ET | 1760 | 15.38 |
11:24 ET | 800 | 15.38 |
11:26 ET | 1688 | 15.44 |
11:27 ET | 2250 | 15.42 |
11:29 ET | 400 | 15.41 |
11:31 ET | 4326 | 15.42 |
11:33 ET | 987 | 15.43 |
11:36 ET | 2868 | 15.49 |
11:38 ET | 1198 | 15.49 |
11:40 ET | 4039 | 15.51 |
11:42 ET | 2427 | 15.4717 |
11:44 ET | 1649 | 15.47 |
11:45 ET | 100 | 15.47 |
11:47 ET | 1424 | 15.485 |
11:49 ET | 423 | 15.49 |
11:51 ET | 500 | 15.48 |
11:54 ET | 2162 | 15.47 |
11:56 ET | 2653 | 15.49 |
11:58 ET | 619 | 15.48 |
12:00 ET | 803 | 15.5 |
12:02 ET | 2095 | 15.51 |
12:03 ET | 2479 | 15.49 |
12:05 ET | 1560 | 15.47 |
12:07 ET | 1863 | 15.46 |
12:09 ET | 700 | 15.46 |
12:12 ET | 6218 | 15.46 |
12:14 ET | 788 | 15.48 |
12:16 ET | 7550 | 15.415 |
12:18 ET | 7943 | 15.34 |
12:20 ET | 3021 | 15.32 |
12:21 ET | 10676 | 15.3 |
12:23 ET | 20722 | 15.27 |
12:25 ET | 5872 | 15.29 |
12:27 ET | 6085 | 15.28 |
12:30 ET | 1301 | 15.28 |
12:32 ET | 1213 | 15.26 |
12:34 ET | 2306 | 15.29 |
12:36 ET | 16229 | 15.28 |
12:38 ET | 1900 | 15.28 |
12:39 ET | 8681 | 15.317937 |
12:41 ET | 8388 | 15.34 |
12:43 ET | 4553 | 15.4 |
12:45 ET | 2003 | 15.4 |
12:48 ET | 7835 | 15.34 |
12:50 ET | 3746 | 15.365 |
12:52 ET | 2230 | 15.37 |
12:54 ET | 1626 | 15.36 |
12:56 ET | 1998 | 15.35 |
12:57 ET | 6746 | 15.34 |
12:59 ET | 3904 | 15.36 |
01:01 ET | 19247 | 15.41 |
01:03 ET | 1912 | 15.38 |
01:06 ET | 1255 | 15.39 |
01:08 ET | 1839 | 15.41 |
01:10 ET | 1271 | 15.39 |
01:12 ET | 827 | 15.3692 |
01:14 ET | 1500 | 15.36 |
01:15 ET | 1934 | 15.366 |
01:17 ET | 4780 | 15.365 |
01:19 ET | 3071 | 15.37 |
01:21 ET | 3248 | 15.325 |
01:24 ET | 2350 | 15.32 |
01:26 ET | 2361 | 15.33 |
01:28 ET | 5971 | 15.285 |
01:30 ET | 1403 | 15.26 |
01:32 ET | 5886 | 15.2475 |
01:33 ET | 4686 | 15.28 |
01:35 ET | 1529 | 15.28 |
01:37 ET | 15936 | 15.305 |
01:39 ET | 13772 | 15.28 |
01:42 ET | 1940 | 15.29 |
01:44 ET | 77747 | 15.29 |
01:46 ET | 2600 | 15.325 |
01:48 ET | 1200 | 15.32 |
01:50 ET | 3519 | 15.29 |
01:51 ET | 1821 | 15.28 |
01:53 ET | 9647 | 15.33 |
01:55 ET | 1358 | 15.3104 |
01:57 ET | 5925 | 15.32 |
02:00 ET | 3068 | 15.3175 |
02:02 ET | 4547 | 15.345 |
02:04 ET | 736 | 15.35 |
02:06 ET | 827 | 15.35 |
02:08 ET | 6053 | 15.36 |
02:09 ET | 6000 | 15.35 |
02:11 ET | 4580 | 15.36 |
02:13 ET | 3263 | 15.3787 |
02:15 ET | 1562 | 15.38 |
02:18 ET | 2710 | 15.36 |
02:20 ET | 2300 | 15.35 |
02:22 ET | 2080 | 15.35 |
02:24 ET | 3060 | 15.35 |
02:26 ET | 3107 | 15.35 |
02:27 ET | 2100 | 15.36 |
02:29 ET | 2800 | 15.37 |
02:31 ET | 3202 | 15.39 |
02:33 ET | 2719 | 15.37 |
02:36 ET | 4817 | 15.38 |
02:40 ET | 7974 | 15.39 |
02:42 ET | 400 | 15.39 |
02:44 ET | 2000 | 15.38 |
02:45 ET | 15753 | 15.3721 |
02:47 ET | 1616 | 15.3678 |
02:49 ET | 4079 | 15.36 |
02:51 ET | 6713 | 15.35 |
02:54 ET | 4868 | 15.35 |
02:56 ET | 3396 | 15.36 |
02:58 ET | 8626 | 15.31 |
03:00 ET | 7052 | 15.32 |
03:02 ET | 7258 | 15.33 |
03:03 ET | 3726 | 15.37 |
03:05 ET | 4335 | 15.37 |
03:07 ET | 5551 | 15.37 |
03:09 ET | 5173 | 15.35 |
03:12 ET | 2949 | 15.36 |
03:14 ET | 5591 | 15.36 |
03:16 ET | 3799 | 15.355 |
03:18 ET | 6933 | 15.365 |
03:20 ET | 11593 | 15.37 |
03:21 ET | 3543 | 15.36 |
03:23 ET | 2138 | 15.36 |
03:25 ET | 7849 | 15.345 |
03:27 ET | 3883 | 15.335 |
03:30 ET | 5691 | 15.345 |
03:32 ET | 3267 | 15.345 |
03:34 ET | 9615 | 15.35 |
03:36 ET | 11404 | 15.365 |
03:38 ET | 3957 | 15.379 |
03:39 ET | 11522 | 15.355 |
03:41 ET | 4444 | 15.365 |
03:43 ET | 13199 | 15.37 |
03:45 ET | 10463 | 15.4 |
03:48 ET | 5943 | 15.395 |
03:50 ET | 5870 | 15.405 |
03:52 ET | 11449 | 15.42 |
03:54 ET | 13059 | 15.395 |
03:56 ET | 22654 | 15.375 |
03:57 ET | 23704 | 15.365 |
03:59 ET | 363608 | 15.32 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ACADIA Pharmaceuticals Inc | 2.6B | 84.5x | --- |
Azenta Inc | 2.4B | -16.6x | --- |
Guardant Health Inc | 2.8B | -5.5x | --- |
PTC Therapeutics Inc | 2.8B | -5.8x | --- |
Novavax Inc | 2.1B | -4.4x | --- |
Catalyst Pharmaceuticals Inc | 2.4B | 37.5x | --- |
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.6B |
---|---|
Revenue (TTM) | $890.5M |
Shares Outstanding | 165.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.39 |
EPS | $0.18 |
Book Value | $2.62 |
P/E Ratio | 84.5x |
Price/Sales (TTM) | 3.0 |
Price/Cash Flow (TTM) | 62.5x |
Operating Margin | 2.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.